Skip to main content
. 2012 Jul 23;7(7):e41787. doi: 10.1371/journal.pone.0041787

Figure 6. The integrity and the reactivity of the antibody produced by this method.

Figure 6

SDS-PAGE of proteins produced by clone CN19-4/1F3. lane1, antibody purified from the clone CN19-4/1F3 culture; lane 2, commercial 9E10 c-MYC antibody; lane 3, immunoblot of the 50 kDa c-MYC fusion protein with the purified antibody from the CN19-4/1F3 culture (lane 3) or the commercial 9E10 c-MYC antibody (lane 4).